KRAS and diffuse large B-cell lymphoma: In this study, similar results were obtained; DLBCL with strongly positive and weakly positive HCV NS3 expressions was mostly found in women (37.0%), in the age group ≥60 years (39.2%), patients with Ann Arbor stages III-IV (40.5%), those with increased LDH levels (22.6%), good ECOG status (19.4%), and centroblastic morphological variants (24.6%).